|

5-azacytidine Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Vidaza, azacytidine

Pipeline

Early 1: 1Phase 2: 1

Top Sponsors

  • Benjamin Tomlinson1
  • Barbara Burtness1

Indications

  • Cancer2
  • MDS/MPN Crossover Syndromes1
  • Squamous Cell Carcinoma of Head and Neck1
  • Myelodysplastic Syndromes1

New Haven, Connecticut1 trial

5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Yale University

Phase 2

Cleveland, Ohio1 trial

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.